These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 20547814)

  • 1. Nationwide investigation of extended-spectrum beta-lactamases, metallo-beta-lactamases, and extended-spectrum oxacillinases produced by ceftazidime-resistant Pseudomonas aeruginosa strains in France.
    Hocquet D; Plésiat P; Dehecq B; Mariotte P; Talon D; Bertrand X;
    Antimicrob Agents Chemother; 2010 Aug; 54(8):3512-5. PubMed ID: 20547814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extended-spectrum and metallo-beta-lactamases among ceftazidime-resistant Pseudomonas aeruginosa in Riyadh, Saudi Arabia.
    Al-Agamy MH; Shibl AM; Tawfik AF; Elkhizzi NA; Livermore DM
    J Chemother; 2012 Apr; 24(2):97-100. PubMed ID: 22546765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular epidemiology of beta-lactamases in ceftazidime-resistant Pseudomonas aeruginosa isolates].
    Er H; Altındiş M; Aşık G; Demir C
    Mikrobiyol Bul; 2015 Apr; 49(2):156-65. PubMed ID: 26167816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of Ambler class A, B and D β-lactamases among Pseudomonas aeruginosa isolates.
    Tawfik AF; Shibl AM; Aljohi MA; Altammami MA; Al-Agamy MH
    Burns; 2012 Sep; 38(6):855-60. PubMed ID: 22348803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of extended spectrum beta-lactamases, metallo-beta-lactamases and AmpC-beta-lactamases among carbapenem resistant Pseudomonas aeruginosa isolated from burn patients.
    Neyestanaki DK; Mirsalehian A; Rezagholizadeh F; Jabalameli F; Taherikalani M; Emaneini M
    Burns; 2014 Dec; 40(8):1556-61. PubMed ID: 24767143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular epidemiology of Pseudomonas aeruginosa clinical isolates from Korea producing β-lactamases with extended-spectrum activity.
    Bae IK; Suh B; Jeong SH; Wang KK; Kim YR; Yong D; Lee K
    Diagn Microbiol Infect Dis; 2014 Jul; 79(3):373-7. PubMed ID: 24792837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Widespread detection of VEB-1-type extended-spectrum beta-lactamases among nosocomial ceftazidime-resistant Pseudomonas aeruginosa isolates in Sofia, Bulgaria.
    Strateva T; Ouzounova-Raykova V; Markova B; Todorova A; Marteva-Proevska Y; Mitov I
    J Chemother; 2007 Apr; 19(2):140-5. PubMed ID: 17434821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outbreak of PER-1 and diversity of β-lactamases among ceftazidime-resistant Pseudomonas aeruginosa clinical isolates.
    Qing Y; Cao KY; Fang ZL; Huang YM; Zhang XF; Tian GB; Huang X
    J Med Microbiol; 2014 Mar; 63(Pt 3):386-392. PubMed ID: 24398232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenging Antimicrobial Susceptibility and Evolution of Resistance (OXA-681) during Treatment of a Long-Term Nosocomial Infection Caused by a Pseudomonas aeruginosa ST175 Clone.
    Arca-Suárez J; Fraile-Ribot P; Vázquez-Ucha JC; Cabot G; Martínez-Guitián M; Lence E; González-Bello C; Beceiro A; Rodríguez-Iglesias M; Galán-Sánchez F; Bou G; Oliver A
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31383659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective survey of beta-lactamases produced by ceftazidime- resistant Pseudomonas aeruginosa isolated in a French hospital in 2000.
    De Champs C; Poirel L; Bonnet R; Sirot D; Chanal C; Sirot J; Nordmann P
    Antimicrob Agents Chemother; 2002 Sep; 46(9):3031-4. PubMed ID: 12183264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of Pseudomonas aeruginosa isolates producing VEB-type extended-spectrum beta-lactamases in the United Kingdom.
    Woodford N; Zhang J; Kaufmann ME; Yarde S; Tomas Mdel M; Faris C; Vardhan MS; Dawson S; Cotterill SL; Livermore DM
    J Antimicrob Chemother; 2008 Dec; 62(6):1265-8. PubMed ID: 18819973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissemination of Pseudomonas aeruginosa producing SPM-1-like and IMP-1-like metallo-beta-lactamases in hospitals from southern Brazil.
    Martins AF; Zavascki AP; Gaspareto PB; Barth AL
    Infection; 2007 Dec; 35(6):457-60. PubMed ID: 18034208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OXA-type beta-lactamases among extended-spectrum cephalosporin-resistant Pseudomonas aeruginosa isolates in a university hospital in southern Taiwan.
    Yan JJ; Tsai SH; Chuang CL; Wu JJ
    J Microbiol Immunol Infect; 2006 Apr; 39(2):130-4. PubMed ID: 16604245
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Karlowsky JA; Kazmierczak KM; Bouchillon SK; de Jonge BLM; Stone GG; Sahm DF
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic detection and polymerase chain reaction screening of extended-spectrum β-lactamases produced by Pseudomonas aeruginosa isolates.
    Lin SP; Liu MF; Lin CF; Shi ZY
    J Microbiol Immunol Infect; 2012 Jun; 45(3):200-7. PubMed ID: 22209695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of Pseudomonas-Derived Cephalosporinase and Metallo-β-Lactamases in Carbapenem-Resistant Pseudomonas aeruginosa Isolates from Korea.
    Cho HH; Kwon GC; Kim S; Koo SH
    J Microbiol Biotechnol; 2015 Jul; 25(7):1154-62. PubMed ID: 25907063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of VEB-1, OXA-10 and PER-1 genotypes in extended-spectrum beta-lactamase-producing Pseudomonas aeruginosa strains isolated from burn patients.
    Mirsalehian A; Feizabadi M; Nakhjavani FA; Jabalameli F; Goli H; Kalantari N
    Burns; 2010 Feb; 36(1):70-4. PubMed ID: 19524369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo selection of oxacillinase-mediated ceftazidime resistance in Pseudomonas aeruginosa.
    Leotard S; Poirel L; Leblanc PE; Nordmann P
    Microb Drug Resist; 2001; 7(3):273-5. PubMed ID: 11759089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonal dissemination of Pseudomonas aeruginosa isolates producing extended-spectrum β-lactamase SHV-2a.
    Jeannot K; Fournier D; Müller E; Cholley P; Plésiat P
    J Clin Microbiol; 2013 Feb; 51(2):673-5. PubMed ID: 23241379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diversity of beta-lactamases produced by ceftazidime-resistant Pseudomonas aeruginosa isolates causing bloodstream infections in Brazil.
    Picão RC; Poirel L; Gales AC; Nordmann P
    Antimicrob Agents Chemother; 2009 Sep; 53(9):3908-13. PubMed ID: 19596871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.